Burning Rock Biotech (BNR) Total Debt (2019 - 2026)

Burning Rock Biotech (BNR) posted quarterly Total Debt of $274304.4 for Q1 2026, up 2.4% on a QoQ basis from $267885.9 in Q4 2025.

Burning Rock Biotech (BNR) Total Debt (2019 - 2026) Analysis & Trends

Burning Rock Biotech (BNR) has reported Total Debt for 5 consecutive years, with $274304.4 the latest figure, recorded in Q1 2026.

In Q1 2026, Total Debt changed N/A year-over-year to $274304.4; the TTM figure through Mar 2026 stood at $274304.4 (changed N/A YoY), while the FY2025 annual figure was $272000.0, changed N/A from the prior year.
Total Debt came in at $274304.4 for Q1 2026 at Burning Rock Biotech, up from $267885.9 in the prior quarter.
The five-year high for Total Debt was $276505.5 in Q2 2025, with the low at $251492.2 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	4.86 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	43.16 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	18.48 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	829.85 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	22.40 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	304.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	15.83 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	1.49 Bn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	2.23 Bn
10	Burning Rock Biotech	748.66 Mn	683.48 Mn	11.31 Mn	274,304.36

Download Data